Dier Mardi's Form 4 filing
Madrigal Pharmaceuticals, Inc. (MDGL) · filed Mar 6, 2026
- Accession no.
- 0001628280-26-015775
- Filed
- Mar 6, 2026
- Trade date
- Mar 4-6, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 13 non-derivative transactions and 1 derivative transaction. Open-market sales total $854.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dier MardiCIK 0001574591 | Officer (EVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Common Stock | AGrant or awardAcquired | +5,215 | $0.00 | $0 | 14,472 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −646 | $431.94 | −$279,033.24 | 13,826 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −40 | $425.08 | −$17,003.2 | 13,786 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −420 | $426.86 | −$179,281.2 | 13,366 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −80 | $427.85 | −$34,228 | 13,286 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −160 | $429.00 | −$68,640 | 13,126 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −40 | $429.58 | −$17,183.2 | 13,086 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −120 | $430.90 | −$51,708 | 12,966 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −116 | $432.56 | −$50,176.96 | 12,850 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −160 | $434.20 | −$69,472 | 12,690 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −80 | $435.32 | −$34,825.6 | 12,610 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −80 | $436.69 | −$34,935.2 | 12,530 | Direct | |
| Mar 6, 2026 | Common Stock | SSaleDisposed | −40 | $437.65 | −$17,506 | 12,490 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Common Stock | AGrant or awardAcquired | +6,519 | $0.00 | $0 | 6,519 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.